We are seeking a Manager, CMC Project Management who is responsible for driving cross-functional execution of CMC activities in support of early and late-stage clinical development programs. Working closely with Technical Operations - including Drug Substance, Drug Product, Analytical Development, Regulatory CMC, Quality, Supply Chain and external partners, this role leads integrated project planning, facilitates cross-functional alignment, manages risks and timelines, and enables successful delivery of CMC milestones in support of regulatory and development objectives. This role is based in Waltham, MA and you must have experience in the oncology space.
Responsibilities
- Lead cross-functional CMC project management for clinical-stage development programs, developing and maintaining integrated project plans, timelines, critical path activities, milestones, risks, and decision logs.
- Drive project execution by facilitating cross-functional meetings, tracking actions and decisions, proactively identifying risks and dependencies, and escalating issues to ensure program objectives are achieved.
- Coordinate activities across Drug Substance, Drug Product, Analytical Development, Quality Control, Quality Assurance, Supply Chain, Regulatory CMC, and other Technical Operations functions to ensure alignment of priorities and deliverables
- Partner with CDMOs, CROs, testing laboratories, and other external vendors to monitor deliverables, manufacturing activities, timelines, and issue resolution.
- Coordinate planning and execution of CMC regulatory submissions, including INDs, IMPDs, amendments, and health authority responses, ensuring cross-functional deliverables are completed on schedule.
- Support program budgeting, forecasting, resource planning, purchase order tracking, and financial reporting to enable effective execution of CMC development activities.
- Identify and implement process improvements to strengthen CMC project execution, governance, resource planning, and organizational effectiveness.
Education & Experience
- Bachelor’s degree in a scientific, engineering, or related discipline required.
- 5–8 years of biotech or pharmaceutical industry experience.
- Experience in CMC, Technical Operations, Project Management, Manufacturing, Supply Chain, or related functions.
- Familiarity with GMP manufacturing and external partner management.
- Strong project management and organizational skills.
- Ability to manage multiple priorities in a fast-paced environment.
- Excellent communication and collaboration skills.
- Experience with project planning and tracking tools.
- Ability to identify risks and drive issue resolution.
- Detail-oriented with strong follow-through and accountability
What We Offer
- Opportunity to join a mission-driven team where you'll contribute to impactful work, take on varied responsibilities, and grow quickly in a dynamic environment
- Competitive compensation, including base salary, performance bonus, and equity
- 100% employer-paid benefits package
- Flexible PTO; also, two, one-week company-wide shutdowns each year
- A commitment to your professional development, with access to resources, mentorship, and growth opportunities
Skills Required
- Bachelor's degree in a scientific, engineering, or related discipline
- 5-8 years of biotech or pharmaceutical industry experience
- Experience in CMC, Technical Operations, Project Management, Manufacturing, Supply Chain, or related functions
- Experience in the oncology space
- Familiarity with GMP manufacturing and external partner management
- Strong project management and organizational skills
- Ability to manage multiple priorities in a fast-paced environment
- Excellent communication and collaboration skills
- Experience with project planning and tracking tools
- Ability to identify risks and drive issue resolution
- Detail-oriented with strong follow-through and accountability
- Role based in Waltham, MA (on-site)
What We Do
Crescent Biopharma, Inc. is a clinical-stage biotechnology company dedicated to advancing the next wave of transformative therapies for cancer patients. The company focuses on developing high-impact cancer medicines, including its lead program, CR-001 (a PD-1 x VEGF bispecific antibody), and a portfolio of novel antibody-drug conjugates (ADCs) designed to treat a range of solid tumors.







